“…Emerging evidence suggests that decision-making could be a useful behavioral biomarker for delineating the biological mechanisms that mediate addiction susceptibility from those that are consequent to drug use (Groman and Jentsch, 2012; Groman et al, 2022). Specifically, we have found that deficits in reward-guided, decision-making prior to any drug exposure are predictive of greater cocaine-taking behaviors in rats (Groman et al, 2020; Villiamma et al, 2022) and associated with neurobiological abnormalities that have been observed in cocaine-dependent individuals (Volkow et al, 1993; Groman et al, 2011, 2020; Payer et al, 2014). Decision-making phenotypes could be used for assessing addiction risk in individuals prior to any drug exposure and, therefore, represent a potentially powerful approach for impeding the ongoing opioid epidemic.…”